[HTML] nature.com

[HTML][HTML] GSK-3 inhibition potentiates the synaptogenic and antidepressant-like effects of subthreshold doses of ketamine

RJ Liu, M Fuchikami, JM Dwyer, AE Lepack… - …, 2013 - nature.com
A single dose of the short-acting NMDA antagonist ketamine produces rapid and prolonged
antidepressant effects in treatment-resistant patients with major depressive disorder (MDD) …
被引用次数：271 相关文章

[引用][C] GSK-3 Inhibition Potentiates the Synaptogenic and Antidepressant-Like Effects of Subthreshold Doses of Ketamine

RJ LIU, M FUCHIKAMI, JM DWYER… - … (New York, NY), 2013 - pascal-francis.inist.fr
GSK-3 Inhibition Potentiates the Synaptogenic and Antidepressant-Like Effects of
Subthreshold Doses of Ketamine CNRS Inist Pascal-Francis CNRS Pascal and Francis …

[引用][C] GSK-3 Inhibition Potentiates the Synaptogenic and Antidepressant-Like Effects of Subthreshold Doses of Ketamine

RJ Liu, M Fuchikami, JM Dwyer, AE Lepack… - …, 2013 - cir.nii.ac.jp
GSK-3 Inhibition Potentiates the Synaptogenic and Antidepressant-Like Effects of Subthreshold
Doses of Ketamine | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …

GSK-3 inhibition potentiates the synaptogenic and antidepressant-like effects of subthreshold doses of ketamine

RJ Liu, M Fuchikami, JM Dwyer… - … publication of the …, 2013 - pubmed.ncbi.nlm.nih.gov
A single dose of the short-acting NMDA antagonist ketamine produces rapid and prolonged
antidepressant effects in treatment-resistant patients with major depressive disorder (MDD) …

GSK-3 inhibition potentiates the synaptogenic and antidepressant-like effects of subthreshold doses of ketamine.

RJ Liu, M Fuchikami, JM Dwyer, AE Lepack… - … : Official Publication of …, 2013 - europepmc.org
A single dose of the short-acting NMDA antagonist ketamine produces rapid and prolonged
antidepressant effects in treatment-resistant patients with major depressive disorder (MDD) …
[HTML] nih.gov

[HTML][HTML] GSK-3 Inhibition Potentiates the Synaptogenic and Antidepressant-Like Effects of Subthreshold Doses of Ketamine

RJ Liu, M Fuchikami, JM Dwyer… - …, 2013 - ncbi.nlm.nih.gov
A single dose of the short-acting NMDA antagonist ketamine produces rapid and prolonged
antidepressant effects in treatment-resistant patients with major depressive disorder (MDD) …
[PDF] academia.edu

[PDF][PDF] GSK-3 Inhibition Potentiates the Synaptogenic and Antidepressant-Like Effects of Subthreshold Doses of Ketamine

RJ Liu, M Fuchikami, JM Dwyer, AE Lepack… - …, 2013 - academia.edu
A single dose of the short-acting NMDA antagonist ketamine produces rapid and prolonged
antidepressant effects in treatment-resistant patients with major depressive disorder (MDD) …
[PDF] researchgate.net

[PDF][PDF] GSK-3 Inhibition Potentiates the Synaptogenic and Antidepressant-Like Effects of Subthreshold Doses of Ketamine

RJ Liu, M Fuchikami, JM Dwyer… - …, 2013 - researchgate.net
A single dose of the short-acting NMDA antagonist ketamine produces rapid and prolonged
antidepressant effects in treatment-resistant patients with major depressive disorder (MDD) …

GSK-3 Inhibition Potentiates the Synaptogenic and Antidepressant-Like Effects of Subthreshold Doses of Ketamine.

RJ Liu, M Fuchikami, JM Dwyer… - …, 2013 - search.ebscohost.com
A single dose of the short-acting NMDA antagonist ketamine produces rapid and prolonged
antidepressant effects in treatment-resistant patients with major depressive disorder (MDD) …

GSK-3 Inhibition Potentiates the Synaptogenic and Antidepressant-Like Effects of Subthreshold Doses of Ketamine.

RJ Liu, M Fuchikami, JM Dwyer… - …, 2013 - search.ebscohost.com
A single dose of the short-acting NMDA antagonist ketamine produces rapid and prolonged
antidepressant effects in treatment-resistant patients with major depressive disorder (MDD) …